Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases

Background. Liver is the commonest site for metastasis in patients with neuroendocrine tumour (NET). A vast majority of treatment strategies including liver directed nonsurgical therapy, liver directed surgical therapy, and nonliver directed therapy have been proposed. In this study we aim to invest...

Full description

Saved in:
Bibliographic Details
Published in:TheScientificWorld 2014-01, Vol.2014 (2014), p.1-7
Main Authors: Fan, Sheung Tat, Lo, Chung Mau, Chan, See Ching, Yau, Thomas, Lang, Brian Hung-Hin, Dai, Jeff W. C., Tsang, Simon, Chan, Albert C.Y., Chok, Kenneth S. H., Cheung, Tan To, Poon, Ronnie Tung-Ping
Format: Article
Language:English
Subjects:
Adult
Aged
Care and treatment
Clinical Study
Comorbidity
Disease
Female
Hepatectomy
Hepatectomy - adverse effects
Hospital Mortality
Hospitalization
Hospitals
Humans
Liver
Liver cancer
Liver Neoplasms - mortality
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Male
Medical imaging
Metastasis
Middle Aged
Mortality
Neuroendocrine tumors
Neuroendocrine Tumors - mortality
Neuroendocrine Tumors - pathology
Pancreas
Patient outcomes
Patients
Pleural effusion
Risk Factors
Surgeons
Surgery
Survival
Survival analysis
Treatment Outcome
Tumors
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Liver is the commonest site for metastasis in patients with neuroendocrine tumour (NET). A vast majority of treatment strategies including liver directed nonsurgical therapy, liver directed surgical therapy, and nonliver directed therapy have been proposed. In this study we aim to investigate the outcome of liver resection in neuroendocrine tumour liver metastases (NELM). Method. 293 patients had hepatectomy for liver metastasis in our hospital between June 1996 and December 2010. Twelve patients were diagnosed to have NET in their final pathology and their data were reviewed. Results. The median ages of the patients were 48.5 years (range 20–71 years). Eight of the patients received major hepatectomy. Four patients received minor hepatectomy. The median operation time was 418 minutes (range 195–660 minutes). The median tumor size was 8.75 cm (range 0.9–21 cm). There was no hospital mortality. The overall one-year and three-year survivals were 91.7% and 55.6%. The one-year and three-year disease-free survivals were 33.3% and 16.7%. Conclusion. Hepatectomy is an effective and safe treatment for NELM. Reasonable outcome on long term overall survival and disease-free survival can be achieved in this group of patients with a low morbidity rate.
ISSN:2356-6140
1537-744X
1537-744X
DOI:10.1155/2014/524045